Sign up for our eNewsletter
[f] [t] [in] [blog]

Portfolio Companies

Bioscience
Clean Technology
Information Technology
Medical Device

AlloMek Therapeutics

About: AlloMek Therapeutics was formed to develop, and out-license, a novel class of MEK inhibitors represented by the lead compound CIP-137401.

Web: http://allomek.optimatrix.net/

CI Representative:
Daniel Wagner
Managing Director, Investments

[photo]